![PRD_000309 PRD_000309](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000309.svg) | PRD_000309 | Name: | L-leucyl-N-(2-oxopropyl)-L-phenylalaninamide | Formula: | C26 H31 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000310 PRD_000310](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/EP0.svg) | PRD_000310 | Name: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-isoleucyl-L-proline | Formula: | C17 H28 N2 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001087 PRD_001087](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/S28.svg) | PRD_001087 | Name: | N-(benzylsulfonyl)glycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | Formula: | C22 H27 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000312 PRD_000312](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0I5.svg) | PRD_000312 | Name: | N-[(3S)-1-fluoro-2-oxo-5-phenylpentan-3-yl]-N~2~-(morpholin-4-ylcarbonyl)-L-leucinamide | Formula: | C22 H32 F N3 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001088 PRD_001088](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001088.svg) | PRD_001088 | Name: | D-peptide inhibitor | Formula: | C75 H106 N17 O17 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000313 PRD_000313](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000313.svg) | PRD_000313 | Name: | MeOSuc-Ala-Ala-Pro-boroIle | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001090 PRD_001090](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/M31.svg) | PRD_001090 | Name: | N-(benzylsulfonyl)glycyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | Formula: | C22 H27 Cl N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000314 PRD_000314](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000314.svg) | PRD_000314 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID | Formula: | C18 H31 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001091 PRD_001091](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001091.svg) | PRD_001091 | Name: | monomeric peptide inhibitor | Formula: | C72 H103 N19 O16 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000315 PRD_000315](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000315.svg) | PRD_000315 | Name: | O-methylsuccinyl-alanyl-alanyl-prolyl-borophenylalanine | Formula: | C24 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001092 PRD_001092](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001092.svg) | PRD_001092 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-cysteinamide | Formula: | C23 H37 N8 O4 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000316 PRD_000316](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000316.svg) | PRD_000316 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-VALINE BORONIC ACID | Formula: | C20 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001093 PRD_001093](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001093.svg) | PRD_001093 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-isoleucinamide | Formula: | C26 H43 N8 O4 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000317 PRD_000317](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000317.svg) | PRD_000317 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-prolinamide | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000318 PRD_000318](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000318.svg) | PRD_000318 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)pentyl]-L-prolinamide | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001095 PRD_001095](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001095.svg) | PRD_001095 | Name: | N~2~-[(2S)-2-{[(benzyloxy)carbonyl]amino}-7-ethoxy-7-oxoheptanoyl]-L-glutaminyl-L-prolyl-L-leucine | Formula: | C33 H49 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000319 PRD_000319](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000319.svg) | PRD_000319 | Name: | methyl N-{(2S,4S,5S)-5-[(L-alanyl-L-alanyl)amino]-2-benzyl-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate | Formula: | C36 H53 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001096 PRD_001096](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001096.svg) | PRD_001096 | Name: | TMC-95A | Formula: | C33 H38 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2020-07-29 |
|
![PRD_000320 PRD_000320](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/PSI.svg) | PRD_000320 | Name: | methyl N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate | Formula: | C29 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000321 PRD_000321](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000321.svg) | PRD_000321 | Name: | N-{(2S)-2-[(L-asparaginyl-L-leucyl)amino]-1,1-dihydroxy-4-methylpentyl}-L-threonyl-L-glutaminyl-L-isoleucine | Formula: | C31 H58 N8 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001098 PRD_001098](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001098.svg) | PRD_001098 | Name: | TMC-95A mimic ligand 2b | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000322 PRD_000322](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0IT.svg) | PRD_000322 | Name: | amino({(4S)-4-[({(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}acetyl)amino]-5-oxopentyl}amino)methaniminium | Formula: | C20 H31 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000323 PRD_000323](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0IU.svg) | PRD_000323 | Name: | (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-[(1S,2R,3R)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-N~4~-[2-(d
imethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenylethyl]butanediamide | Formula: | C34 H53 N5 O5 S | Definition date: | 2012-12-12 | Last modified: | 2022-03-02 |
|
![PRD_001100 PRD_001100](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/S29.svg) | PRD_001100 | Name: | N-(benzylsulfonyl)-D-alanyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | Formula: | C23 H29 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000324 PRD_000324](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0IV.svg) | PRD_000324 | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3R)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | Formula: | C23 H34 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|